Advertisement
Home Tags Cancer: Leukemia

Tag: Cancer: Leukemia

Tool Could Optimize Antibiotic Prescribing for UTI

Sitagliptin Promising Addition for Preventing Acute GVHD

Low incidence of grade II to IV acute GVHD seen in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation

Factors Associated With Suicide in Leukemia Identified

Oral Azacitidine Benefits Some Older Adults With AML

Overall, relapse-free survival prolonged among older patients in first remission after chemo who receive CC-486 versus placebo

Integrated Palliative and Oncology Care Improves QOL in Leukemia

Those receiving IPC were more likely to report discussing end-of-life preferences, were less likely to receive chemo at end of life

ASH: Stem Cell Transplant Benefits Older Adults With MDS

Overall survival, leukemia-free survival higher for patients assigned to allogeneic HCT versus those with no donor

HealthDay Reports: Black Americans Appear Most Vulnerable to Coronavirus

ASH: Black Race Linked to Poorer Survival in AML

Among AML patients treated on Alliance protocols, Blacks versus Whites had inferior disease-free, overall survival

Predictors of Late Effects in Young AML Survivors Explored

Most common late effects were endocrine, cardiovascular, respiratory; likelihood of late effects up for those who underwent HSCT

Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults

Complete remission, overall survival seen in 98, 95 percent of patients in phase 2 study
Male sex

Factors Associated With Suicide in Leukemia Identified

Risk factors include male sex, older age at diagnosis, White race
For patients with acute myeloid leukemia

Measurable Residual Disease Negativity Tied to Survival in AML

AML patients without MRD have higher estimated rates of five-year disease-free, overall survival
Contemporary survivors of childhood acute lymphoblastic leukemia have reduced late morbidity and mortality

Late Morbidity, Mortality Down for Survivors of Childhood ALL

Compared with 1970s, rate of subsequent malignant neoplasms lower with standard-risk 1990s-like therapy